Visit our booth (#37) at ECP to learn how our quantitative pathology solutions can help analyze complex relationships among tumor and immune cells in the tumor micro-environment. Our imaging systems and reagent solutions can deliver per-cell...

Collaboration for Companion Diagnostics that Support Targeted Therapies NUSSLOCH, GERMANY, August 7, 2014. Leica Biosystems, today announced an agreement with Bristol- Myers Squibb Company (NYSE: BMY) to collaborate on developing...

You're Invited to Attend a Free Webinar: "Advances in Neurotechniques: Methods that Reveal the Structure and Function of the Brain" Wednesday, August 13, 2014, 12:00 PM U.S. ET Featured Speakers: Karl Deisseroth, M.D., Ph.D, Stanford...

If you ask anyone who has been involved with digital pathology for the past 5 years or more that has studied the market from their respective perches, "Is the digital pathology market worth $200 million or $2 billion?" their answer would...

Nearly every day there seems to be exciting news or developments in the field of immunotherapy and immuno-oncology.  Not only can you read all about immunotherapy research in leading scientific journals1, but the mainstream media now reports...

Medicine of course over the years has become increasingly technical. Imaging in particular has replaced, in my opinion, much of the art of medicine and replaced it with science.  With advanced imaging techniques old questions get replaced with...